Intent to Sole Source - BD FACSCanto II instrument

This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: BD Biosciences. Acquisition Description: Flow cytometry is a critical technology used for immunophenotyping, cellular analysis, and functional assessment of immune cells in both clinical and research settings. Our laboratory’s BD FACSCanto™ II flow cytometer has been in service for an extended period and requires routine preventive maintenance and timely technical support to ensure reliable operation and minimize downtime. BD Biosciences is the manufacturer of the BD™ flow cytometry system and provides specialized maintenance services, technical expertise, and support specific to this system. The annual service agreement includes two preventive maintenance inspections and PM kits, one business day guaranteed response for emergency on-site service, unlimited service visits, software revisions released during the agreement period, and telephone support for instrument, reagents and application issues. The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-27-000233) by 12:00 PM eastern standard time on 10/23/2026 to: [email protected]. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.